Document ID: chunk:federal_register_of_legislation:F2022L00259:reg:9:p2
Version: federal_register_of_legislation:F2022L00259
Segment Type: reg
Provision Reference: reg 9 (pt 2/4)
Character Range: 7159–10149

Dictionary.
(13)      taking a drug from the Specified List 1 of drugs, where that drug cannot be ceased or substituted, for a continuous period of at least the 28 days before the clinical onset of hypertension;
Note: Specified List 1 of drugs is defined in the Schedule 1 - Dictionary.
(14)      taking a drug from the Specified List 2 of drugs at the time of the clinical onset of hypertension;
Note: Specified List 2 of drugs is defined in the Schedule 1 - Dictionary.
(15)      having glucocorticoid therapy as specified before the clinical onset of hypertension, and if the glucocorticoid therapy as specified has ceased or decreased before the clinical onset of hypertension, then that onset occurred within 30 days of cessation or reduction of therapy;
Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(16)      taking medroxyprogesterone acetate or megestrol acetate for a malignant disease or human immunodeficiency virus infection:
            (a)          for at least 28 days before the clinical onset of hypertension; and
            (b)          if treatment has ceased before the clinical onset of hypertension, then that onset occurred within 30 days of cessation;
(17)      inability to undertake any physical activity greater than 3 METs for at least the 1 year before the clinical onset of hypertension;
Note: MET is defined in the Schedule 1 - Dictionary.
(18)      being exposed to arsenic as specified before the clinical onset of hypertension;
Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(19)      being overweight or obese for at least the 5 years before the clinical worsening of hypertension;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(20)      consuming an average of at least 400 grams of alcohol per week for a continuous period of at least the 6 months before the clinical worsening of hypertension;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(21)      consuming an average of at least 12 grams (200 millimoles) of salt per day for at least the 1 year before the clinical worsening of hypertension;
            Note: Sodium-containing medications may contribute to daily salt intake. Sodium-containing medications include the effervescent or soluble version of standard medicines, such as acetaminophen, ascorbic acid, aspirin, calcium carbonate, ibuprofen, sodium bicarbonate and zinc sulphate.
(22)      having renal artery stenosis at the time of the clinical worsening of hypertension;
            Note: Causes of renal artery stenosis include renal artery atherosclerotic disease and fibromuscular dysplasia.
(23)      having a solid organ, stem cell or bone marrow transplant before the clinical worsening of hypertension;
(24)      having diabetes mellitus for at least the 5 years before the clinical worsening of hypertension;
(25)      having